SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
Victor RazukMauro ChiaritoDavide CaoJohny NicolasCarlo A PivatoAnton CamajDavid PowerFrans J BeerkensDavis JonesAviv AlterAlvin MathewAlessandro SpiritoJohanna P ContrerasGeorge D DangasRoxana MehranPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
SGLT-2 inhibitors improved CV outcomes irrespective of heart failure history or type, and severity of LVEF reduction.